Evidence map›Paper›PMID 35246141›Full record

ArticleJournal of translational medicine2022

The association between bilirubin and hypertension among a Chinese ageing cohort: a prospective follow-up study.

Chen Tang, Hanxiang Jiang, Bin Zhao, Yi Lin, Shengnan Lin, Tianmu Chen, Yanhua Su, Yiqin Zhang, Lina Zhou, Lianmeng Li and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Chen Tang *State Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Hanxiang Jiang *Xiamen Guankou Hospital, No. 270 Jingshan Road, Jimei District, Xiamen, 361023, Fujian, People's Republic of China.
Bin Zhao *Clinical Medical Laboratory, Xiang'an Hospital of Xiamen University, No. 2000, East Xiang'an Road, Xiamen, 361102, Fujian, People's Republic of China.
Yi LinState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Shengnan LinState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Tianmu ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Yanhua SuState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Yiqin ZhangDepartment of Nephrology, The Second Affiliated Hospital of Xiamen Medical College, No. 566 Shengguang Road, Jimei District, Xiamen, 361021, Fujian, People's Republic of China.
Lina ZhouDepartment of Nephrology, The Second Affiliated Hospital of Xiamen Medical College, No. 566 Shengguang Road, Jimei District, Xiamen, 361021, Fujian, People's Republic of China.
Lianmeng LiXiamen Guankou Hospital, No. 270 Jingshan Road, Jimei District, Xiamen, 361023, Fujian, People's Republic of China.
Jincheng LinXiamen Guankou Hospital, No. 270 Jingshan Road, Jimei District, Xiamen, 361023, Fujian, People's Republic of China.
Zhonghua LuState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Yao WangState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Zeyu ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China.
Longjian LiuDepartment of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, 3141 Chestnut Street, Philadelphia, PA, USA.
Yuxin WangDepartment of Nephrology, The Second Affiliated Hospital of Xiamen Medical College, No. 566 Shengguang Road, Jimei District, Xiamen, 361021, Fujian, People's Republic of China. 3146786287@qq.com.
Jie ZhangState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China. jie.zhang@xmu.edu.cn.
Heqing ShenState Key Laboratory of Molecular Vaccinology and Molecular Diagnotics, School of Public Health, Xiamen University, No. 4221-117 South Xiang'an Road, Xiang'an District, Xiamen, 361102, Fujian, People's Republic of China. hqshen@xmu.edu.cn.
Xiamen University · CNThe Second Affiliated Hospital of Xiamen Medical CollegeDrexel University · US

Funding

Fundamental Research Funds for the Central Universities No. 20720190074National Natural Science Foundation of China No. 22076157Planning Guidance Project of Fujian Provincial Department of Science and Technology 2019D015
6 · The paper itself

Abstract

backgroundHypertension is highly prevalent and associated with the elevated risks of cardiovascular diseases, dementia, and physical disabilities among adults. Although the correlation between bilirubin and hypertension has been reported, the observation in quinquagenarian population is scarce. We aimed to examine bilirubin-hypertension association in Guankou Ageing Cohort Study.

methodsParticipants ≥ 55 years were recruited and their questionnaires and physical examination data were collected. Kaplan-Meier survival analysis and Cox proportional hazards regression were implemented to assess the hypertension risk. The non-liner dose-response relationships of bilirubin-hypertension were determined by restricted cubic spline (RCS) models. Receiver operating characteristic (ROC) curves and multiple factors analysis (MFA) were performed to evaluate the predictive abilities.

results1881 eligible participants (male 43.75%, female 56.25%) with the median age of 61.00 (59.00-66.00) were included. The hazard ratio (HR, 95% CI) of serum total bilirubin (STB) and unconjugated bilirubin (UCB) were 1.03 (1.01-1.05) and 1.05 (1.03-1.07), while conjugated bilirubin (CB) showed a weak protective effect with the HR of 0.96 (0.92-0.99), and the associations remained significant in all models. RCS analyses further indicated the similar bidirectional effects of STB and UCB with the cut-off of 12.17 μmol/L and 8.59 μmol/L, while CB exhibited inverse bidirectional dose-response relationship with a cut-off of 3.47 μmol/L. ROC curves and MFA showed baseline STB combined with age, BMI, and waist circumference could well discriminate the low and high of hypertension risk.

conclusionsOur findings suggested the higher levels of total and unconjugated bilirubin were hazardous factors of hypertension, while an inverse effect presented when more bilirubin was conjugated.

Indexed as

BilirubinHypertensionAdultAgingChinaCohort StudiesFemaleFollow-Up StudiesHumansMaleProspective StudiesRisk FactorsBilirubinAgeingBilirubinCohort studyHypertension

Identifiers

PMID35246141
PMCPMC8895624
OpenAlexW4214834868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.